Oxilan-350

   
Google
 
Web NewDrugInformation.com

Oxilan-350


Drug - Oxilan-350
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ioxilan
Multiple ingredients are in alphabetical order.

Strength - 73%
The potency of the active ingredient(s), Ioxilan. May repeat for multiple part products.

Applicant - GUERBET
The firm name holding legal responsibility for Oxilan-350. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020316
The FDA assigned number to Oxilan-350. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Oxilan-350. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 21, 1995
The date Oxilan-350 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Oxilan-350. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Oxilan-350 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Guerbet Llc
The full name of the firm holding legal responsibility for the new application of Oxilan-350.

Oxilan-350